HRS 22: Findings From a Sub-Analysis of EAST-AFNET 4

Published: 05 May 2022

  • Views:

    Views Icon 255
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

In this short interview from HRS 2022, Dr Andreas Rillig (University Heart and Vascular Center Hamburg, Hamburg, DE) joins us to discuss the outcomes of a sub-analysis of EAST-AFNET4. This multicentre randomised trial compared the strategy of early initiation of rhythm-control therapy with usual care in patients with heart failure.

Discussion points: 
1. Aim of this sub-analysis
2. Patient cohort and study design
3. Main findings
4. Findings in relation to main cohort of EAST-AFNET4
5. Take-home messages for clinicians

Recorded onsite at HRS 2022, San Francisco.

Videography:Dan Brent